Advertisement
Screener

LifeStance Health Group, Inc. (LFST) Quick Ratio

LifeStance Health Group, Inc. (LFST) Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..

Quick ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations274.75M USDLiabilities, Current
Cash and equivalents225.94M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables110.96M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2026-06-30(m)$274.75M$225.94M(m)$110.96M(m)(m)
2026-03-31(m)$239.73M$194.80M(m)$122.92M(m)(m)
2025-12-31(m)$251.96M$248.64M(m)$95.71M(m)(m)
2025-09-30(m)$228.56M$203.90M(m)$121.07M(m)(m)
2025-06-30(m)$242.28M$188.93M(m)$129.48M(m)(m)
2025-03-31(m)$207.38M$134.34M(m)$140.37M(m)(m)
2024-12-31(m)$228.89M$154.57M(m)$131.80M(m)(m)
2024-09-30(m)$217.51M$102.61M(m)$158.16M(m)(m)
2024-06-30(m)$227.66M$86.97M(m)$167.22M(m)(m)
2024-03-31(m)$207.46M$49.45M(m)$175.94M(m)(m)
2023-12-31(m)$202.87M$78.82M(m)$125.41M(m)(m)
2023-09-30(m)$240.87M$42.60M(m)$149.72M(m)(m)
2023-06-30(m)$180.85M$79.61M(m)$121.80M(m)(m)
2023-03-31(m)$181.14M$68.29M(m)$118.38M(m)(m)
2022-12-31(m)$176.00M$108.62M(m)$100.87M(m)(m)
2022-09-30(m)$112.27M$90.34M(m)$113.28M(m)(m)
2022-06-30(m)$111.54M$96.69M(m)$99.74M(m)(m)
2022-03-31(m)$125.60M$113.99M(m)$94.99M(m)(m)
2021-12-31(m)$116.75M$148.03M(m)$76.08M(m)(m)
2021-09-30(m)$105.20M$212.12M(m)$70.06M(m)(m)
2021-06-30(m)$112.56M$276.19M(m)$60.07M(m)(m)
2020-12-31(m)$75.92M$18.83M(m)$43.71M(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B